Sangamo BioSciences, Inc. Presents Clinical Data From SB-728-T HIV Study Demonstrating Long-Term Immune Reconstitution and Reduction in the HIV DNA Reservoir in Subjects With Long-Term Infection /PRNewswire/ -- Sangamo BioSciences, Inc. announced today the presentation of clinical data from its program to develop a ZFP TherapeuticA for HIV/AIDS.
http://www.biospace.com/news_story.aspx?StoryID=314210&full=1
http://www.biospace.com/news_story.aspx?StoryID=314210&full=1
No comments:
Post a Comment